nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—ALB—coronary artery disease	0.277	1	CbGaD
Gadobenate Dimeglumine—ALB—Pitavastatin—coronary artery disease	0.0832	0.19	CbGbCtD
Gadobenate Dimeglumine—ALB—Valsartan—coronary artery disease	0.081	0.185	CbGbCtD
Gadobenate Dimeglumine—ALB—Rosuvastatin—coronary artery disease	0.0614	0.14	CbGbCtD
Gadobenate Dimeglumine—ALB—Acetylsalicylic acid—coronary artery disease	0.0598	0.136	CbGbCtD
Gadobenate Dimeglumine—ALB—Captopril—coronary artery disease	0.0591	0.135	CbGbCtD
Gadobenate Dimeglumine—ALB—Furosemide—coronary artery disease	0.0475	0.108	CbGbCtD
Gadobenate Dimeglumine—ALB—Losartan—coronary artery disease	0.0465	0.106	CbGbCtD
Gadobenate Dimeglumine—ALB—Hemostasis—PPBP—coronary artery disease	6.19e-05	0.00105	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—ITGA2B—coronary artery disease	6.08e-05	0.00104	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—SLC27A1—coronary artery disease	6.06e-05	0.00103	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—KNG1—coronary artery disease	6.05e-05	0.00103	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—HK2—coronary artery disease	6.01e-05	0.00102	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CPT1B—coronary artery disease	5.94e-05	0.00101	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—LCAT—coronary artery disease	5.94e-05	0.00101	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—PTGS2—coronary artery disease	5.93e-05	0.00101	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—ATP2B1—coronary artery disease	5.9e-05	0.001	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PLG—coronary artery disease	5.86e-05	0.000997	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—APOA4—coronary artery disease	5.83e-05	0.000992	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—F3—coronary artery disease	5.82e-05	0.00099	CbGpPWpGaD
Gadobenate Dimeglumine—Gastrointestinal pain—Perindopril—coronary artery disease	5.78e-05	0.000256	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Timolol—coronary artery disease	5.78e-05	0.000256	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Lisinopril—coronary artery disease	5.77e-05	0.000256	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Olmesartan—coronary artery disease	5.77e-05	0.000255	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—CKMT1B—coronary artery disease	5.76e-05	0.000981	CbGpPWpGaD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	5.76e-05	0.000255	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	5.76e-05	0.00098	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ATP4A—coronary artery disease	5.76e-05	0.00098	CbGpPWpGaD
Gadobenate Dimeglumine—Body temperature increased—Captopril—coronary artery disease	5.76e-05	0.000255	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Captopril—coronary artery disease	5.76e-05	0.000255	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Simvastatin—coronary artery disease	5.74e-05	0.000254	CcSEcCtD
Gadobenate Dimeglumine—Rash—Ezetimibe—coronary artery disease	5.74e-05	0.000254	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Ezetimibe—coronary artery disease	5.74e-05	0.000254	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Ramipril—coronary artery disease	5.73e-05	0.000254	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Timolol—coronary artery disease	5.73e-05	0.000254	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Niacin—coronary artery disease	5.72e-05	0.000253	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Losartan—coronary artery disease	5.72e-05	0.000253	CcSEcCtD
Gadobenate Dimeglumine—Headache—Ezetimibe—coronary artery disease	5.7e-05	0.000252	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Lisinopril—coronary artery disease	5.7e-05	0.000252	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Ramipril—coronary artery disease	5.69e-05	0.000252	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Timolol—coronary artery disease	5.67e-05	0.000251	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Losartan—coronary artery disease	5.67e-05	0.000251	CcSEcCtD
Gadobenate Dimeglumine—Pain—Losartan—coronary artery disease	5.67e-05	0.000251	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Lisinopril—coronary artery disease	5.67e-05	0.000251	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Eplerenone—coronary artery disease	5.67e-05	0.000251	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Furosemide—coronary artery disease	5.66e-05	0.000251	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Lisinopril—coronary artery disease	5.66e-05	0.00025	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—SELL—coronary artery disease	5.66e-05	0.000963	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—ANGPT2—coronary artery disease	5.66e-05	0.000963	CbGpPWpGaD
Gadobenate Dimeglumine—Nausea—Fenofibrate—coronary artery disease	5.65e-05	0.00025	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Niacin—coronary artery disease	5.64e-05	0.00025	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Pravastatin—coronary artery disease	5.63e-05	0.000249	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PRKCE—coronary artery disease	5.63e-05	0.000959	CbGpPWpGaD
Gadobenate Dimeglumine—Gastrointestinal pain—Furosemide—coronary artery disease	5.62e-05	0.000249	CcSEcCtD
Gadobenate Dimeglumine—Rash—Eplerenone—coronary artery disease	5.62e-05	0.000249	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—SOD1—coronary artery disease	5.62e-05	0.000956	CbGpPWpGaD
Gadobenate Dimeglumine—Urticaria—Perindopril—coronary artery disease	5.62e-05	0.000249	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Trandolapril—coronary artery disease	5.62e-05	0.000249	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Eplerenone—coronary artery disease	5.61e-05	0.000248	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Valsartan—coronary artery disease	5.61e-05	0.000248	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Timolol—coronary artery disease	5.61e-05	0.000248	CcSEcCtD
Gadobenate Dimeglumine—Shock—Ramipril—coronary artery disease	5.6e-05	0.000248	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Enalapril—coronary artery disease	5.59e-05	0.000248	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Perindopril—coronary artery disease	5.59e-05	0.000247	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Perindopril—coronary artery disease	5.59e-05	0.000247	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Lisinopril—coronary artery disease	5.58e-05	0.000247	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Olmesartan—coronary artery disease	5.58e-05	0.000247	CcSEcCtD
Gadobenate Dimeglumine—Headache—Eplerenone—coronary artery disease	5.58e-05	0.000247	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Ramipril—coronary artery disease	5.58e-05	0.000247	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Timolol—coronary artery disease	5.56e-05	0.000246	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Pravastatin—coronary artery disease	5.55e-05	0.000246	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Lisinopril—coronary artery disease	5.55e-05	0.000246	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Clopidogrel—coronary artery disease	5.55e-05	0.000246	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Ramipril—coronary artery disease	5.55e-05	0.000246	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Ramipril—coronary artery disease	5.52e-05	0.000244	CcSEcCtD
Gadobenate Dimeglumine—Infection—Timolol—coronary artery disease	5.52e-05	0.000244	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Simvastatin—coronary artery disease	5.52e-05	0.000244	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—IL1B—coronary artery disease	5.52e-05	0.00094	CbGpPWpGaD
Gadobenate Dimeglumine—Hypersensitivity—Telmisartan—coronary artery disease	5.52e-05	0.000244	CcSEcCtD
Gadobenate Dimeglumine—Cough—Lisinopril—coronary artery disease	5.51e-05	0.000244	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Lovastatin—coronary artery disease	5.51e-05	0.000244	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—F5—coronary artery disease	5.51e-05	0.000938	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SELP—coronary artery disease	5.51e-05	0.000938	CbGpPWpGaD
Gadobenate Dimeglumine—Hyperhidrosis—Ramipril—coronary artery disease	5.5e-05	0.000243	CcSEcCtD
Gadobenate Dimeglumine—Rash—Simvastatin—coronary artery disease	5.48e-05	0.000242	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Simvastatin—coronary artery disease	5.47e-05	0.000242	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Trandolapril—coronary artery disease	5.47e-05	0.000242	CcSEcCtD
Gadobenate Dimeglumine—Shock—Timolol—coronary artery disease	5.47e-05	0.000242	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Losartan—coronary artery disease	5.47e-05	0.000242	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Furosemide—coronary artery disease	5.46e-05	0.000242	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Niacin—coronary artery disease	5.46e-05	0.000241	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—TXNRD1—coronary artery disease	5.45e-05	0.000928	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CYP11B2—coronary artery disease	5.45e-05	0.000928	CbGpPWpGaD
Gadobenate Dimeglumine—Nervous system disorder—Timolol—coronary artery disease	5.45e-05	0.000241	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Enalapril—coronary artery disease	5.45e-05	0.000241	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—SLC8A1—coronary artery disease	5.45e-05	0.000927	CbGpPWpGaD
Gadobenate Dimeglumine—Headache—Simvastatin—coronary artery disease	5.44e-05	0.000241	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Furosemide—coronary artery disease	5.43e-05	0.00024	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Furosemide—coronary artery disease	5.43e-05	0.00024	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Losartan—coronary artery disease	5.42e-05	0.00024	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Valsartan—coronary artery disease	5.42e-05	0.00024	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Ezetimibe—coronary artery disease	5.41e-05	0.000239	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Timolol—coronary artery disease	5.4e-05	0.000239	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Olmesartan—coronary artery disease	5.4e-05	0.000239	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Trandolapril—coronary artery disease	5.39e-05	0.000239	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—GATA4—coronary artery disease	5.38e-05	0.000916	CbGpPWpGaD
Gadobenate Dimeglumine—Arthralgia—Lisinopril—coronary artery disease	5.38e-05	0.000238	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Lisinopril—coronary artery disease	5.38e-05	0.000238	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Lisinopril—coronary artery disease	5.38e-05	0.000238	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Timolol—coronary artery disease	5.37e-05	0.000238	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Telmisartan—coronary artery disease	5.37e-05	0.000238	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Enalapril—coronary artery disease	5.37e-05	0.000238	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Pravastatin—coronary artery disease	5.37e-05	0.000238	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Lisinopril—coronary artery disease	5.36e-05	0.000237	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	5.34e-05	0.000236	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Lisinopril—coronary artery disease	5.32e-05	0.000235	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Ramipril—coronary artery disease	5.31e-05	0.000235	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Telmisartan—coronary artery disease	5.3e-05	0.000234	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Eplerenone—coronary artery disease	5.29e-05	0.000234	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—HADH—coronary artery disease	5.29e-05	0.000901	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—ARNTL—coronary artery disease	5.29e-05	0.000901	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Niacin—coronary artery disease	5.27e-05	0.000233	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Losartan—coronary artery disease	5.27e-05	0.000233	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Lisinopril—coronary artery disease	5.26e-05	0.000233	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Losartan—coronary artery disease	5.24e-05	0.000232	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Losartan—coronary artery disease	5.24e-05	0.000232	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Captopril—coronary artery disease	5.23e-05	0.000231	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Trandolapril—coronary artery disease	5.22e-05	0.000231	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Valsartan—coronary artery disease	5.21e-05	0.000231	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Lisinopril—coronary artery disease	5.2e-05	0.00023	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Enalapril—coronary artery disease	5.2e-05	0.00023	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Timolol—coronary artery disease	5.2e-05	0.00023	CcSEcCtD
Gadobenate Dimeglumine—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—coronary artery disease	5.19e-05	0.000884	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Pravastatin—coronary artery disease	5.19e-05	0.00023	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Olmesartan—coronary artery disease	5.19e-05	0.00023	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Ramipril—coronary artery disease	5.18e-05	0.000229	CcSEcCtD
Gadobenate Dimeglumine—Rash—Valsartan—coronary artery disease	5.17e-05	0.000229	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Valsartan—coronary artery disease	5.17e-05	0.000229	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Simvastatin—coronary artery disease	5.16e-05	0.000228	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Lisinopril—coronary artery disease	5.16e-05	0.000228	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Captopril—coronary artery disease	5.15e-05	0.000228	CcSEcCtD
Gadobenate Dimeglumine—Rash—Olmesartan—coronary artery disease	5.15e-05	0.000228	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Olmesartan—coronary artery disease	5.14e-05	0.000227	CcSEcCtD
Gadobenate Dimeglumine—Headache—Valsartan—coronary artery disease	5.14e-05	0.000227	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Telmisartan—coronary artery disease	5.12e-05	0.000227	CcSEcCtD
Gadobenate Dimeglumine—Infection—Lisinopril—coronary artery disease	5.12e-05	0.000227	CcSEcCtD
Gadobenate Dimeglumine—Headache—Olmesartan—coronary artery disease	5.11e-05	0.000226	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	5.11e-05	0.000869	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	5.11e-05	0.000869	CbGpPWpGaD
Gadobenate Dimeglumine—Paraesthesia—Ramipril—coronary artery disease	5.11e-05	0.000226	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—P2RY12—coronary artery disease	5.09e-05	0.000867	CbGpPWpGaD
Gadobenate Dimeglumine—Shock—Lisinopril—coronary artery disease	5.07e-05	0.000225	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Perindopril—coronary artery disease	5.07e-05	0.000224	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Ramipril—coronary artery disease	5.07e-05	0.000224	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Niacin—coronary artery disease	5.07e-05	0.000224	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Timolol—coronary artery disease	5.07e-05	0.000224	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Furosemide—coronary artery disease	5.06e-05	0.000224	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Ramipril—coronary artery disease	5.06e-05	0.000224	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet degranulation—VEGFA—coronary artery disease	5.04e-05	0.000859	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—TNF—coronary artery disease	5.04e-05	0.000858	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Trandolapril—coronary artery disease	5.04e-05	0.000223	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—HGF—coronary artery disease	5.04e-05	0.000858	CbGpPWpGaD
Gadobenate Dimeglumine—Tachycardia—Lisinopril—coronary artery disease	5.03e-05	0.000223	CcSEcCtD
Gadobenate Dimeglumine—Rash—Niacin—coronary artery disease	5.03e-05	0.000222	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Niacin—coronary artery disease	5.02e-05	0.000222	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Enalapril—coronary artery disease	5.02e-05	0.000222	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PLA2G2A—coronary artery disease	5.02e-05	0.000854	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—APOA2—coronary artery disease	5.02e-05	0.000854	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—GPX2—coronary artery disease	5.02e-05	0.000854	CbGpPWpGaD
Gadobenate Dimeglumine—Skin disorder—Lisinopril—coronary artery disease	5.01e-05	0.000222	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Ramipril—coronary artery disease	5.01e-05	0.000222	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Perindopril—coronary artery disease	5e-05	0.000221	CcSEcCtD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—IL6—coronary artery disease	5e-05	0.000851	CbGpPWpGaD
Gadobenate Dimeglumine—Headache—Niacin—coronary artery disease	5e-05	0.000221	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Timolol—coronary artery disease	4.99e-05	0.000221	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Pravastatin—coronary artery disease	4.99e-05	0.000221	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Lisinopril—coronary artery disease	4.99e-05	0.000221	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Captopril—coronary artery disease	4.98e-05	0.00022	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—CSF2—coronary artery disease	4.98e-05	0.000848	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—GPX4—coronary artery disease	4.96e-05	0.000844	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—ABCG5—coronary artery disease	4.96e-05	0.000844	CbGpPWpGaD
Gadobenate Dimeglumine—Dyspnoea—Timolol—coronary artery disease	4.96e-05	0.000219	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Telmisartan—coronary artery disease	4.95e-05	0.000219	CcSEcCtD
Gadobenate Dimeglumine—Rash—Pravastatin—coronary artery disease	4.95e-05	0.000219	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Pravastatin—coronary artery disease	4.95e-05	0.000219	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—GNA12—coronary artery disease	4.94e-05	0.000842	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—THBD—coronary artery disease	4.94e-05	0.000842	CbGpPWpGaD
Gadobenate Dimeglumine—Somnolence—Timolol—coronary artery disease	4.94e-05	0.000219	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Furosemide—coronary artery disease	4.93e-05	0.000218	CcSEcCtD
Gadobenate Dimeglumine—Headache—Pravastatin—coronary artery disease	4.92e-05	0.000218	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Ramipril—coronary artery disease	4.91e-05	0.000217	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Ramipril—coronary artery disease	4.9e-05	0.000217	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—HADHA—coronary artery disease	4.9e-05	0.000834	CbGpPWpGaD
Gadobenate Dimeglumine—Dyspepsia—Timolol—coronary artery disease	4.89e-05	0.000217	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Losartan—coronary artery disease	4.89e-05	0.000216	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Valsartan—coronary artery disease	4.87e-05	0.000216	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Furosemide—coronary artery disease	4.86e-05	0.000215	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Ramipril—coronary artery disease	4.86e-05	0.000215	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Olmesartan—coronary artery disease	4.85e-05	0.000215	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Trandolapril—coronary artery disease	4.85e-05	0.000214	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Perindopril—coronary artery disease	4.84e-05	0.000214	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Enalapril—coronary artery disease	4.83e-05	0.000214	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Lisinopril—coronary artery disease	4.82e-05	0.000213	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Captopril—coronary artery disease	4.82e-05	0.000213	CcSEcCtD
Gadobenate Dimeglumine—Rash—Trandolapril—coronary artery disease	4.81e-05	0.000213	CcSEcCtD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—coronary artery disease	4.81e-05	0.000818	CbGpPWpGaD
Gadobenate Dimeglumine—Dermatitis—Trandolapril—coronary artery disease	4.8e-05	0.000213	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Timolol—coronary artery disease	4.8e-05	0.000212	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Timolol—coronary artery disease	4.79e-05	0.000212	CcSEcCtD
Gadobenate Dimeglumine—Rash—Enalapril—coronary artery disease	4.79e-05	0.000212	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—LPA—coronary artery disease	4.79e-05	0.000815	CbGpPWpGaD
Gadobenate Dimeglumine—Dermatitis—Enalapril—coronary artery disease	4.78e-05	0.000212	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—ITGB3—coronary artery disease	4.78e-05	0.000813	CbGpPWpGaD
Gadobenate Dimeglumine—Headache—Trandolapril—coronary artery disease	4.78e-05	0.000211	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Telmisartan—coronary artery disease	4.76e-05	0.000211	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Losartan—coronary artery disease	4.76e-05	0.000211	CcSEcCtD
Gadobenate Dimeglumine—Headache—Enalapril—coronary artery disease	4.76e-05	0.00021	CcSEcCtD
Gadobenate Dimeglumine—Pain—Timolol—coronary artery disease	4.75e-05	0.00021	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Niacin—coronary artery disease	4.74e-05	0.00021	CcSEcCtD
Gadobenate Dimeglumine—Rash—Telmisartan—coronary artery disease	4.72e-05	0.000209	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Telmisartan—coronary artery disease	4.72e-05	0.000209	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—HK1—coronary artery disease	4.71e-05	0.000802	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	4.71e-05	0.000802	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ABCG5—coronary artery disease	4.71e-05	0.000802	CbGpPWpGaD
Gadobenate Dimeglumine—Diarrhoea—Furosemide—coronary artery disease	4.7e-05	0.000208	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—CD36—coronary artery disease	4.7e-05	0.0008	CbGpPWpGaD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	4.7e-05	0.000208	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—CKM—coronary artery disease	4.7e-05	0.000799	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—UQCRFS1—coronary artery disease	4.7e-05	0.000799	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PPAP2B—coronary artery disease	4.7e-05	0.000799	CbGpPWpGaD
Gadobenate Dimeglumine—Pruritus—Losartan—coronary artery disease	4.69e-05	0.000208	CcSEcCtD
Gadobenate Dimeglumine—Headache—Telmisartan—coronary artery disease	4.69e-05	0.000208	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—SELE—coronary artery disease	4.69e-05	0.000798	CbGpPWpGaD
Gadobenate Dimeglumine—Feeling abnormal—Ramipril—coronary artery disease	4.69e-05	0.000207	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Perindopril—coronary artery disease	4.68e-05	0.000207	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Pravastatin—coronary artery disease	4.66e-05	0.000206	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Ramipril—coronary artery disease	4.65e-05	0.000206	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Lisinopril—coronary artery disease	4.63e-05	0.000205	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Captopril—coronary artery disease	4.63e-05	0.000205	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet degranulation—TGFB1—coronary artery disease	4.63e-05	0.000788	CbGpPWpGaD
Gadobenate Dimeglumine—Dyspnoea—Lisinopril—coronary artery disease	4.6e-05	0.000203	CcSEcCtD
Gadobenate Dimeglumine—Rash—Captopril—coronary artery disease	4.59e-05	0.000203	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—APOA5—coronary artery disease	4.59e-05	0.000781	CbGpPWpGaD
Gadobenate Dimeglumine—Dermatitis—Captopril—coronary artery disease	4.59e-05	0.000203	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Lisinopril—coronary artery disease	4.59e-05	0.000203	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Timolol—coronary artery disease	4.58e-05	0.000203	CcSEcCtD
Gadobenate Dimeglumine—Headache—Captopril—coronary artery disease	4.56e-05	0.000202	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PRKCD—coronary artery disease	4.56e-05	0.000776	CbGpPWpGaD
Gadobenate Dimeglumine—Gastrointestinal pain—Timolol—coronary artery disease	4.55e-05	0.000201	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Furosemide—coronary artery disease	4.55e-05	0.000201	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Lisinopril—coronary artery disease	4.54e-05	0.000201	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—ALDOA—coronary artery disease	4.54e-05	0.000773	CbGpPWpGaD
Gadobenate Dimeglumine—Diarrhoea—Losartan—coronary artery disease	4.54e-05	0.000201	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Trandolapril—coronary artery disease	4.53e-05	0.0002	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Ramipril—coronary artery disease	4.52e-05	0.0002	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Enalapril—coronary artery disease	4.51e-05	0.0002	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—P4HB—coronary artery disease	4.5e-05	0.000766	CbGpPWpGaD
Gadobenate Dimeglumine—Vomiting—Perindopril—coronary artery disease	4.5e-05	0.000199	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Ramipril—coronary artery disease	4.5e-05	0.000199	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Ramipril—coronary artery disease	4.5e-05	0.000199	CcSEcCtD
Gadobenate Dimeglumine—Rash—Perindopril—coronary artery disease	4.46e-05	0.000197	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Perindopril—coronary artery disease	4.45e-05	0.000197	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Lisinopril—coronary artery disease	4.45e-05	0.000197	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Telmisartan—coronary artery disease	4.45e-05	0.000197	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Lisinopril—coronary artery disease	4.45e-05	0.000197	CcSEcCtD
Gadobenate Dimeglumine—Headache—Perindopril—coronary artery disease	4.43e-05	0.000196	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PLA2G1B—coronary artery disease	4.42e-05	0.000752	CbGpPWpGaD
Gadobenate Dimeglumine—Urticaria—Timolol—coronary artery disease	4.42e-05	0.000195	CcSEcCtD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—coronary artery disease	4.41e-05	0.000751	CbGpPWpGaD
Gadobenate Dimeglumine—Pain—Lisinopril—coronary artery disease	4.41e-05	0.000195	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Lisinopril—coronary artery disease	4.41e-05	0.000195	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Timolol—coronary artery disease	4.4e-05	0.000194	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Timolol—coronary artery disease	4.4e-05	0.000194	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Losartan—coronary artery disease	4.39e-05	0.000194	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Furosemide—coronary artery disease	4.37e-05	0.000193	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—CKMT2—coronary artery disease	4.37e-05	0.000743	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PDK4—coronary artery disease	4.37e-05	0.000743	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SULT4A1—coronary artery disease	4.37e-05	0.000743	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PYGM—coronary artery disease	4.37e-05	0.000743	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ALDH6A1—coronary artery disease	4.37e-05	0.000743	CbGpPWpGaD
Gadobenate Dimeglumine—Rash—Furosemide—coronary artery disease	4.33e-05	0.000192	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Furosemide—coronary artery disease	4.33e-05	0.000192	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Captopril—coronary artery disease	4.33e-05	0.000191	CcSEcCtD
Gadobenate Dimeglumine—Headache—Furosemide—coronary artery disease	4.31e-05	0.000191	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Lisinopril—coronary artery disease	4.25e-05	0.000188	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—CRK—coronary artery disease	4.23e-05	0.00072	CbGpPWpGaD
Gadobenate Dimeglumine—Gastrointestinal pain—Lisinopril—coronary artery disease	4.22e-05	0.000187	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Losartan—coronary artery disease	4.22e-05	0.000187	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Perindopril—coronary artery disease	4.2e-05	0.000186	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Ramipril—coronary artery disease	4.19e-05	0.000185	CcSEcCtD
Gadobenate Dimeglumine—Rash—Losartan—coronary artery disease	4.18e-05	0.000185	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Losartan—coronary artery disease	4.18e-05	0.000185	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—SH2B3—coronary artery disease	4.18e-05	0.000711	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—VWF—coronary artery disease	4.18e-05	0.000711	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—ATP2A2—coronary artery disease	4.18e-05	0.000711	CbGpPWpGaD
Gadobenate Dimeglumine—Headache—Losartan—coronary artery disease	4.16e-05	0.000184	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—APOA1—coronary artery disease	4.1e-05	0.000698	CbGpPWpGaD
Gadobenate Dimeglumine—Urticaria—Lisinopril—coronary artery disease	4.1e-05	0.000181	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Timolol—coronary artery disease	4.1e-05	0.000181	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Furosemide—coronary artery disease	4.08e-05	0.000181	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Ramipril—coronary artery disease	4.08e-05	0.000181	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Lisinopril—coronary artery disease	4.08e-05	0.00018	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Lisinopril—coronary artery disease	4.08e-05	0.00018	CcSEcCtD
Gadobenate Dimeglumine—ALB—Folate Metabolism—IL6—coronary artery disease	4.07e-05	0.000693	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—MAPK14—coronary artery disease	4.03e-05	0.000687	CbGpPWpGaD
Gadobenate Dimeglumine—Pruritus—Ramipril—coronary artery disease	4.02e-05	0.000178	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—TNF—coronary artery disease	4.01e-05	0.000682	CbGpPWpGaD
Gadobenate Dimeglumine—Asthenia—Timolol—coronary artery disease	3.99e-05	0.000177	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—F7—coronary artery disease	3.99e-05	0.000678	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—F2R—coronary artery disease	3.99e-05	0.000678	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SPARC—coronary artery disease	3.99e-05	0.000678	CbGpPWpGaD
Gadobenate Dimeglumine—Nausea—Losartan—coronary artery disease	3.94e-05	0.000174	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Timolol—coronary artery disease	3.93e-05	0.000174	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—F2—coronary artery disease	3.91e-05	0.000666	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—FN1—coronary artery disease	3.91e-05	0.000666	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—IRF1—coronary artery disease	3.9e-05	0.000664	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—FGB—coronary artery disease	3.9e-05	0.000664	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GYG1—coronary artery disease	3.89e-05	0.000662	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GK—coronary artery disease	3.89e-05	0.000662	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PFKM—coronary artery disease	3.89e-05	0.000662	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HMGCS2—coronary artery disease	3.89e-05	0.000662	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—LDHA—coronary artery disease	3.89e-05	0.000662	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GATM—coronary artery disease	3.89e-05	0.000662	CbGpPWpGaD
Gadobenate Dimeglumine—Diarrhoea—Ramipril—coronary artery disease	3.89e-05	0.000172	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—TGFB2—coronary artery disease	3.82e-05	0.00065	CbGpPWpGaD
Gadobenate Dimeglumine—Diarrhoea—Timolol—coronary artery disease	3.8e-05	0.000168	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—LIPC—coronary artery disease	3.8e-05	0.000647	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CYP2C19—coronary artery disease	3.8e-05	0.000647	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—coronary artery disease	3.8e-05	0.000647	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—THBS1—coronary artery disease	3.8e-05	0.000647	CbGpPWpGaD
Gadobenate Dimeglumine—Hypersensitivity—Lisinopril—coronary artery disease	3.8e-05	0.000168	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—APOC3—coronary artery disease	3.78e-05	0.000643	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Ramipril—coronary artery disease	3.76e-05	0.000166	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—LDLR—coronary artery disease	3.76e-05	0.00064	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—AK1—coronary artery disease	3.71e-05	0.000632	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GCH1—coronary artery disease	3.71e-05	0.000632	CbGpPWpGaD
Gadobenate Dimeglumine—Asthenia—Lisinopril—coronary artery disease	3.7e-05	0.000164	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Timolol—coronary artery disease	3.68e-05	0.000163	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CETP—coronary artery disease	3.67e-05	0.000625	CbGpPWpGaD
Gadobenate Dimeglumine—Pruritus—Lisinopril—coronary artery disease	3.65e-05	0.000161	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—SDC1—coronary artery disease	3.63e-05	0.000618	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	3.62e-05	0.000616	CbGpPWpGaD
Gadobenate Dimeglumine—Vomiting—Ramipril—coronary artery disease	3.62e-05	0.00016	CcSEcCtD
Gadobenate Dimeglumine—Rash—Ramipril—coronary artery disease	3.59e-05	0.000159	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Ramipril—coronary artery disease	3.58e-05	0.000159	CcSEcCtD
Gadobenate Dimeglumine—Headache—Ramipril—coronary artery disease	3.56e-05	0.000158	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—MDH2—coronary artery disease	3.56e-05	0.000606	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PLCD1—coronary artery disease	3.56e-05	0.000606	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—UGCG—coronary artery disease	3.56e-05	0.000606	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PPAT—coronary artery disease	3.56e-05	0.000606	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—TIMP1—coronary artery disease	3.55e-05	0.000605	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PLAT—coronary artery disease	3.55e-05	0.000605	CbGpPWpGaD
Gadobenate Dimeglumine—Vomiting—Timolol—coronary artery disease	3.54e-05	0.000156	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	3.53e-05	0.000601	CbGpPWpGaD
Gadobenate Dimeglumine—Diarrhoea—Lisinopril—coronary artery disease	3.53e-05	0.000156	CcSEcCtD
Gadobenate Dimeglumine—Rash—Timolol—coronary artery disease	3.51e-05	0.000155	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Timolol—coronary artery disease	3.5e-05	0.000155	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—CETP—coronary artery disease	3.49e-05	0.000594	CbGpPWpGaD
Gadobenate Dimeglumine—Headache—Timolol—coronary artery disease	3.48e-05	0.000154	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—PGM1—coronary artery disease	3.43e-05	0.000583	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—IGF1—coronary artery disease	3.43e-05	0.000583	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Lisinopril—coronary artery disease	3.41e-05	0.000151	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Ramipril—coronary artery disease	3.38e-05	0.000149	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	3.35e-05	0.00057	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	3.32e-05	0.000565	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CKB—coronary artery disease	3.31e-05	0.000563	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PYGB—coronary artery disease	3.31e-05	0.000563	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—TFRC—coronary artery disease	3.31e-05	0.000563	CbGpPWpGaD
Gadobenate Dimeglumine—Nausea—Timolol—coronary artery disease	3.3e-05	0.000146	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Lisinopril—coronary artery disease	3.28e-05	0.000145	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—SERPINE1—coronary artery disease	3.25e-05	0.000554	CbGpPWpGaD
Gadobenate Dimeglumine—Rash—Lisinopril—coronary artery disease	3.25e-05	0.000144	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Lisinopril—coronary artery disease	3.25e-05	0.000144	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—IL6—coronary artery disease	3.23e-05	0.00055	CbGpPWpGaD
Gadobenate Dimeglumine—Headache—Lisinopril—coronary artery disease	3.23e-05	0.000143	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—ITGAV—coronary artery disease	3.13e-05	0.000532	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—KNG1—coronary artery disease	3.12e-05	0.000531	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GSTM2—coronary artery disease	3.11e-05	0.00053	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PLIN1—coronary artery disease	3.11e-05	0.00053	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—DLAT—coronary artery disease	3.11e-05	0.00053	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—COX5B—coronary artery disease	3.11e-05	0.00053	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PFKFB3—coronary artery disease	3.11e-05	0.00053	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PLAUR—coronary artery disease	3.09e-05	0.000526	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—PLAT—coronary artery disease	3.08e-05	0.000523	CbGpPWpGaD
Gadobenate Dimeglumine—Nausea—Lisinopril—coronary artery disease	3.06e-05	0.000136	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—IFNA2—coronary artery disease	3.05e-05	0.00052	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PLG—coronary artery disease	3.02e-05	0.000514	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—JAK2—coronary artery disease	3.02e-05	0.000514	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	2.96e-05	0.000503	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SULT1E1—coronary artery disease	2.95e-05	0.000502	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PRKCE—coronary artery disease	2.9e-05	0.000494	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SOD1—coronary artery disease	2.9e-05	0.000493	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	2.86e-05	0.000488	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—AKR1B1—coronary artery disease	2.81e-05	0.000479	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HK2—coronary artery disease	2.81e-05	0.000479	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SLC27A1—coronary artery disease	2.7e-05	0.000459	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—APOB—coronary artery disease	2.67e-05	0.000455	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CPT1B—coronary artery disease	2.65e-05	0.00045	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—LCAT—coronary artery disease	2.65e-05	0.00045	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—PLG—coronary artery disease	2.61e-05	0.000445	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—HGF—coronary artery disease	2.6e-05	0.000442	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—APOA4—coronary artery disease	2.6e-05	0.000442	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—CSF2—coronary artery disease	2.57e-05	0.000437	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	2.55e-05	0.000434	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PDHA1—coronary artery disease	2.51e-05	0.000427	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GCLM—coronary artery disease	2.51e-05	0.000427	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—ITGB3—coronary artery disease	2.46e-05	0.000419	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	2.43e-05	0.000414	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—TXNRD1—coronary artery disease	2.43e-05	0.000413	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CYP11B2—coronary artery disease	2.43e-05	0.000413	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—CD36—coronary artery disease	2.42e-05	0.000412	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—HMOX1—coronary artery disease	2.41e-05	0.000411	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SLC22A3—coronary artery disease	2.39e-05	0.000407	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PPP2CA—coronary artery disease	2.39e-05	0.000407	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HADH—coronary artery disease	2.36e-05	0.000401	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ARNTL—coronary artery disease	2.36e-05	0.000401	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PRKCD—coronary artery disease	2.35e-05	0.0004	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	2.32e-05	0.000395	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—APOB—coronary artery disease	2.31e-05	0.000393	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	2.26e-05	0.000385	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—VEGFA—coronary artery disease	2.24e-05	0.000381	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PLA2G2A—coronary artery disease	2.24e-05	0.00038	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—APOA2—coronary artery disease	2.24e-05	0.00038	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GPX2—coronary artery disease	2.24e-05	0.00038	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—MMP1—coronary artery disease	2.21e-05	0.000376	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HK1—coronary artery disease	2.21e-05	0.000376	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SULT1A1—coronary artery disease	2.21e-05	0.000376	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GPX4—coronary artery disease	2.21e-05	0.000376	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ABCG5—coronary artery disease	2.21e-05	0.000376	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	2.21e-05	0.000375	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HADHA—coronary artery disease	2.18e-05	0.000371	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PLAU—coronary artery disease	2.17e-05	0.000369	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GSTA1—coronary artery disease	2.16e-05	0.000367	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—LPA—coronary artery disease	2.13e-05	0.000363	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—APOA1—coronary artery disease	2.11e-05	0.00036	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—MAPK14—coronary artery disease	2.08e-05	0.000354	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PLCB3—coronary artery disease	2.07e-05	0.000352	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—TGFB1—coronary artery disease	2.05e-05	0.00035	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—APOA5—coronary artery disease	2.04e-05	0.000348	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—F2—coronary artery disease	2.02e-05	0.000343	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—FN1—coronary artery disease	2.02e-05	0.000343	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—MAPK1—coronary artery disease	2.01e-05	0.000343	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—P4HB—coronary artery disease	2e-05	0.000341	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—NOS2—coronary artery disease	1.99e-05	0.000339	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	1.99e-05	0.000338	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PLA2G1B—coronary artery disease	1.97e-05	0.000335	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.95e-05	0.000331	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.92e-05	0.000327	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—VCAN—coronary artery disease	1.85e-05	0.000316	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ALDOA—coronary artery disease	1.84e-05	0.000313	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—APOA1—coronary artery disease	1.83e-05	0.000311	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—DCN—coronary artery disease	1.79e-05	0.000304	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—IGF1—coronary artery disease	1.77e-05	0.000301	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PIK3CA—coronary artery disease	1.75e-05	0.000298	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ALDH2—coronary artery disease	1.74e-05	0.000296	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.69e-05	0.000288	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HBA1—coronary artery disease	1.69e-05	0.000288	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—LIPC—coronary artery disease	1.69e-05	0.000288	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CYP2C19—coronary artery disease	1.69e-05	0.000288	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PIK3C2A—coronary artery disease	1.69e-05	0.000288	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—APOC3—coronary artery disease	1.68e-05	0.000287	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SERPINE1—coronary artery disease	1.68e-05	0.000285	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—LDLR—coronary artery disease	1.67e-05	0.000285	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.67e-05	0.000285	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GSTT1—coronary artery disease	1.65e-05	0.000281	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SLC9A1—coronary artery disease	1.65e-05	0.000281	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CETP—coronary artery disease	1.63e-05	0.000278	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GCLC—coronary artery disease	1.63e-05	0.000278	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SDC1—coronary artery disease	1.62e-05	0.000275	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—NOS3—coronary artery disease	1.6e-05	0.000273	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—JAK2—coronary artery disease	1.56e-05	0.000265	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PSMA6—coronary artery disease	1.53e-05	0.00026	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PSMB5—coronary artery disease	1.53e-05	0.00026	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CTGF—coronary artery disease	1.49e-05	0.000254	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GOT2—coronary artery disease	1.48e-05	0.000252	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HMGCR—coronary artery disease	1.48e-05	0.000252	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—AKT1—coronary artery disease	1.43e-05	0.000243	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PLCB1—coronary artery disease	1.36e-05	0.000231	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.33e-05	0.000227	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ABCA1—coronary artery disease	1.32e-05	0.000224	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GGT1—coronary artery disease	1.28e-05	0.000217	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GOT1—coronary artery disease	1.28e-05	0.000217	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—VEGFA—coronary artery disease	1.15e-05	0.000196	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GSTP1—coronary artery disease	1.15e-05	0.000195	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PPARGC1A—coronary artery disease	1.14e-05	0.000193	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HMOX1—coronary artery disease	1.13e-05	0.000192	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CAT—coronary artery disease	1.12e-05	0.00019	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—APOB—coronary artery disease	1.08e-05	0.000184	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—TGFB1—coronary artery disease	1.06e-05	0.00018	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GSTM1—coronary artery disease	1.05e-05	0.000179	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—MAPK1—coronary artery disease	1.04e-05	0.000177	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—LPL—coronary artery disease	1.03e-05	0.000176	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GPX1—coronary artery disease	1.01e-05	0.000172	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CD36—coronary artery disease	9.82e-06	0.000167	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PPP2CA—coronary artery disease	9.7e-06	0.000165	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—MTHFR—coronary artery disease	9.31e-06	0.000158	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PIK3CA—coronary artery disease	9.01e-06	0.000153	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—AGT—coronary artery disease	8.84e-06	0.000151	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—APOE—coronary artery disease	8.66e-06	0.000147	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—APOA1—coronary artery disease	8.57e-06	0.000146	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	8.2e-06	0.00014	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PPARG—coronary artery disease	7.55e-06	0.000128	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—POMC—coronary artery disease	7.44e-06	0.000127	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—AKT1—coronary artery disease	7.36e-06	0.000125	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NOS3—coronary artery disease	6.49e-06	0.00011	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PTGS2—coronary artery disease	5.94e-06	0.000101	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PIK3CA—coronary artery disease	3.65e-06	6.22e-05	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—AKT1—coronary artery disease	2.98e-06	5.08e-05	CbGpPWpGaD
